![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
| Item Type: | Article |
|---|---|
| Title: | Second-line treatment in pancreatic cancer patients: Who profits? Results from the CONKO study group |
| Creators Name: | Sinn, M., Daelken, L., Striefler, J.K., Bischoff, S., Schweitzer, N., Pelzer, U., Doerken, B., Riess, H. and Stieler, J.M. |
| Abstract: | OBJECTIVES: With increasing numbers of therapeutic options in inoperable pancreatic cancer (PAC), patients tend to receive more than just a first line (FL) therapy. METHODS: All patients who started FL for PAC at our institution (1997-2012) were retrospectively studied to identify patient's and treatment characteristics. Significant parameters in regard to second-line (SL) related survival were looked for as the basis for a prognostic model. This score was validated in a patient cohort from the CONKO-003 study. RESULTS: Two hundred eighty of 521 (53.7%) patients received SL therapy, median overall survival (OS) from the beginning of SL (OS2) was 5.1 months. Significant more SL patients had undergone surgery, a higher Karnofsky performance state (KPS) and a duration of FL longer than 4 months.Prognostic factors impacting OS2 were KPS, carbohydrate antigen 19-9 levels at start of SL and the duration of FL. These 3 factors establish a prognostic score-validated in CONKO-003-for SL patients with 3 subgroups: "good" (median OS2, 9.3 months), "intermediate" (median OS2, 7.1 months), "poor" prognosis (median OS2, 3.8 months; P < 0.001). CONCLUSIONS: Among patients with PAC, more than 50% receive SL therapy. Our prognostic model identifies 3 subgroups and can identify patients with a maximum benefit of SL therapy. |
| Keywords: | Pancreatic Cancer, Second-Line Therapy, Chemotherapy, Prognostic Score, CONKO-003 |
| Source: | Pancreas |
| ISSN: | 0885-3177 |
| Publisher: | Lippincott Williams & Wilkins |
| Volume: | 45 |
| Number: | 4 |
| Page Range: | 601-605 |
| Date: | April 2016 |
| Official Publication: | https://doi.org/10.1097/MPA.0000000000000533 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
